Potassium-Competitive Acid Blocker: Novel Class of Anti- Acid Drug

Journal Title: Current Trends in Gastroenterology and Hepatology - Year 2019, Vol 2, Issue 2

Abstract

Over the past several decades, great progress has been made on understanding mechanisms of gastric acid secretion for developing new anti-acid drugs. Until now most commonly used anti-acid drugs are histamine-2 receptor antagonists and proton pump inhibitors (PPIs) for patients to control acid related disease. However, several clinical limitations of these drugs had been reported. Recently, a new generation of potassium-competitive acid blockers (P-CABs) were launched for clinical use. It has been shown that these new drugs are more convenient and powerful to treat gastric acid-related diseases. In this article, we briefly reviewed the clinical use of this new anti-acid drug P-CAB.

Authors and Affiliations

Jaeyong Han MD, Seung Hun Lee MD, Tong Wang MD

Keywords

Related Articles

Description of Plasma Concentrations of Free Amino Acids with Some Clinical Symptoms of Patients Under 5 with Short Bowel Syndrome

Amino acid (AA) is the main component of proteins. Changes in levels of plasma AA concentration have been mentioned in some cases such as plasma AA concentrations in chronic kidney disease (CKD) patients are low when inf...

New Possibilities of Diagnostics of Non-Alcoholic Fatty Liver Disease

The aim of the study was to create a non-invasive model for diagnosing fibrosis and steatosis in non-alcoholic fatty liver disease. Materials and methods. The study included 183 patients with liver steatosis according to...

Hispanic Ethnicity is Associated with Milder Disease Severity in Crohn’s Disease but not Ulcerative Colitis

Background: The incidence of inflammatory bowel disease (IBD) is rising among minority patients; however, few studies have examined racial/ethnic disparities in epidemiology, disease severity, and treatment course. Aim:...

Over View of Gastro Intestinal Diseases in UAE

One fifth of the population in UAE suffers from gastrointestinal diseases including obesity, reflux disease and fatty liver because of obesity, poor diets and close marriage, Acid reflux, ulcerative colitis and irritable...

The Role of Transabdominal Sonography in the Diagnostics of Choledocholithiasis: Compared to Endoscopic Retrograde Cholangiopancreatography

Common bile duct stone (CBDS) or choledocholithiasis (ChL) is one of the major pathologies that lead to serious complications, and accurate and early diagnosis is very important. ChL diagnostics is based on clinical, lab...

Download PDF file
  • EP ID EP573132
  • DOI 10.32474/CTGH.2019.02.000131
  • Views 62
  • Downloads 0

How To Cite

Jaeyong Han MD, Seung Hun Lee MD, Tong Wang MD (2019). Potassium-Competitive Acid Blocker: Novel Class of Anti- Acid Drug. Current Trends in Gastroenterology and Hepatology, 2(2), 121-122. https://europub.co.uk./articles/-A-573132